Guidelines for the examination of pharmaceutical patents: developing a public health perspective
Series: Working papers Published by : WHO, UNCTAD and ICTSD (Geneva, Switzerland) Physical details: viii-56 pages ISSN:1684-9825 Year: 2007| Item type | Current location | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Book
|
Main Library Intellectual Property | Non-fiction | 346.0486 Correa_WHO-UNCTAD-ICTSD_IP_Patents:209 | Available | 209-0 |
This paper is intended to be a contribution towards the improvement of transparency and efficiency of patentability examination for pharmaceuticals inventions, particularly in developing countries. It proposes a set of general guidelines for the assessment of some of the common modalities of pharmaceutical patent claims, and suggests elements for the development of public health-sensitive guidelines for the evaluation and review of pharmaceutical patents at the national level. It examines the practices of some patent offices and suggests some mechanisms that may be adopted to incorporate public health perspectives in procedures for the granting of pharmaceutical patents.
Click on an image to view it in the image viewer
There are no comments on this title.